Navigation Links
XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
Date:3/20/2008

VALLEY COTTAGE, N.Y., March 20 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL), a biopharmaceutical company engaged in the acquisition and development of therapeutics for the treatment of unmet medical needs, particularly diabetic neuropathic pain and hepatitis C, today announced its financial results for the year ended December 31, 2007.

At December 31, 2007, the Company had cash, cash equivalents and short- term bank deposits of $13.0 million, compared to $25.2 million at December 31, 2006. The decrease of $12.2 million during the year ended December 31, 2007 was attributable primarily to the Company's $7.5 million initial upfront license payment made in connection with the in-licensing of Bicifadine, a serotonin and norepinephrine reuptake inhibitor for the treatment of diabetic neuropathic pain, in January 2007, operating expenditures associated with the Phase 2b clinical trial of Bicifadine, the development of the DOS hepatitis C pre-clinical program, and operating expenditures associated with the Company's legacy hepatitis C clinical programs that were terminated in 2007, offset by $8.8 million in net proceeds from the private placement that was completed in November 2007.

The loss for the year ended December 31, 2007 was $24.9 million, or $0.11 per ordinary share, compared to a loss of $15.1 million, or $0.08 per ordinary share, for the year ended December 31, 2006, representing an increase in net loss of $9.8 million. The increased loss was primarily attributable to the $7.5 million upfront license fee in connection with the in-licensing of Bicifadine and additional costs associated with the Bicifadine clinical program, offset by lower costs associated with the Company's legacy hepatit
'/>"/>

SOURCE XTL Biopharmaceuticals Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
2. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
3. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
4. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
5. Perrigo Company Announces Launch of Clobetasol Propionate Foam
6. Batesville Holdings Announces New Board of Directors in Preparation for March 31 Spin-Off from Hillenbrand Industries
7. ReBuilder Medical Technologies, Inc. Announces Revolutionary Electronic Zapper Said to Destroy Molluscum Contagiosum Pathogen
8. Lifeway Foods Announces Expanded Distribution and Growing Success of ProBugs(TM) Organic Kefir for Kids
9. Dreier LLP Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated (VRTX)
10. Blue Cross and Blue Shield of Illinois Announces Wellness Tools and Resources
11. Blue Cross and Blue Shield of Illinois Announces Campaign to Address Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Let’s face it: very few are luckily gifted ... majority of people to be uncomfortable with the color of ... addiction or simply genetics, yellowish or stained teeth suppresses confidence ... , Herald Square Dental is proud to announce the ... White Max. , Teeth become discolored for a number ...
(Date:5/24/2013)... Chino, CA (PRWEB) May 24, 2013 Area ... huge selection of new hot tubs to choose from at ... Super Sale . The sales event takes place at ... May 26, 2013. , Jacuzzi, the industry's leading hot ... sale traveling across the country. The event will feature popular ...
(Date:5/24/2013)... 24, 2013 The nation’s first trial ... Surgical Inc.’s da Vinci Surgical System concluded yesterday, Bernstein ... Washington State Court jury ruled in a 10-to-2 decision ... surgeon who performed a da Vinci prostatectomy on a ... family had alleged in their lawsuit that the da ...
(Date:5/24/2013)... of infantile myofibromatosis (IM)a disorder characterized by multiple tumors ... therapeutic targets, according to researchers from the Icahn School ... the American Journal of Human Genetics , may ... for which the only current treatment option is repeated ... inheritied disorder that develops in infancy or even in ...
(Date:5/24/2013)... 24, 2013 BestSatelliteProviders.com the online ... thousands of consumers compare the features and services ... site recently released the rankings of the best ... available for viewing on their website. , ... According to Adam Matthews, the spokesperson for BestSatelliteProviders.com, ...
Breaking Medicine News(10 mins):Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 3Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2Health News:Best Rural Internet Service Provider in 2013 by BestSatelliteProviders.com 2
... State Quality and Cost Council Public Reporting Mandate , ... Partners (MHQP), a local non-profit health care quality collaborative, has ... consulting services to the Massachusetts Health Care Quality and Cost ... and includes developing a plan for the reporting of comparative ...
... of Life, Inc., ( www.gardenoflife.com ) a leading ... up with WomenHeart, the National Coalition for Women with Heart ... women living with or at risk of heart disease. , ... of Life President Brian Ray said the company intends to ...
... KoolDocs.com, ... and more, has launched its new website. Perfect for those who are without health ... from acute medical conditions with quality, affordable medical services over the telephone, email, video, ... ...
... ... HealthForumOnline (HFO), announces a new CE/CEU course entitled A Review ... and Coordination of Care of the Pain Patient to their extensive ... professionals, nurses and allied healthcare workers. While there is an ...
... ... caregivers and families, has been redesigned. New features include video clips, podcasts, social networking ... ... a wealth of information and news updates about Hepatitis C , announces a ...
... that lifestyle risk factors such as alcohol consumption and cigarette ... shown that people who consume the largest quantities of alcohol ... risk of developing the cancer, compared with non-drinkers. ... greater risk of developing bowel cancer - the same risk ...
Cached Medicine News:Health News:Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative 2Health News:Massachusetts Health Quality Partners Awarded Consulting Contract for State Quality and Cost Reporting Initiative 3Health News:Garden of Life Partners with WomenHeart to Help Combat Women's Heart Disease 2Health News:KoolDocs.com, Leading Provider of Online Doctor Consultations, Launches New Website 2Health News:HealthForumOnline Offers New Online CE/CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 2Health News:HealthForumOnline Offers New Online CE/CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 3Health News:HealthForumOnline Offers New Online CE/CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 4Health News:Resource for Those Living with Hepatitis C Announces Website Redesign 2Health News:Alcohol and smoking are key causes for bowel cancer 2
(Date:5/24/2013)... 2013 Solta Medical, Inc. (NASDAQ: SLTM ... reported Dr. Edward W. Knowlton has ... effective immediately.  Dr. Knowlton is the founder of Thermage, the ... director since 1996. "On behalf of the entire ... would like to thank Ed for his tireless dedication to ...
(Date:5/24/2013)... 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ... the Deutsche Bank Health Care Conference to be held ... Adrian Adams , Chief Executive Officer ... the Company and its product pipeline at 12:00 p.m. ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation will ...
(Date:5/24/2013)... GARDEN CITY, England and ... Heptares Therapeutics, the leading GPCR drug discovery and development company, is ... Usui as a Consultant to augment the Company,s business ... territories. Mr Usui has more than 15 years of ... industry including senior roles at Perlegen Sciences, Inc., Roche Pharma ( ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... SyncMedical LLC today announced that the Brazilian ANVISA ... Surveillance Agency) has approved their Ethos Spine ... Spine product line was developed to fulfill the need ... in the ever-growing, ever-changing field of spine surgery. The ...
... 5, 2011 CentraState Healthcare System announced today ... provide state-of-the-art health information exchange (HIE) services to ... laboratories, and other clinicians within its broad medical ... MobileMD to deploy its 4D HIE™, which is ...
Cached Medicine Technology:SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil 2CentraState Healthcare System Selects MobileMD for Health Information Exchange; Introduces EMR Light to Healthcare Community 2CentraState Healthcare System Selects MobileMD for Health Information Exchange; Introduces EMR Light to Healthcare Community 3
... The Quinton Q-Stress Cardiac Stress ... baseline wander and muscle artifact ... second to provide the highest ... Leads can be displayed in ...
... cardiac diagnosis, the fully featured CH2000 Stress ... stress test system that measures T-wave alternans ... check provides a quality control facility, this ... dynamically filters the signal ensuring outstanding and ...
... Marco's CP-690E Automatic Chart Projector makes refracting easier ... program up to 33 charts in any order ... in a darkened room simply by pressing one ... the next chart. In addition, the CP-690E's programmable ...
The Urchin heart positioner provides excellent access to target coronaries while minimizing hemodynamic instability...
Medicine Products: